ArticleEye (London, England)2026

The ADJUST trial and its implications for biologic discontinuation in juvenile idiopathic arthritis-associated uveitis.

Panayiotis Maghsoudlou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.